<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE Annotation PUBLIC "-//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN" "../GENIAtypes/GENIA_event_20.dtd">
<Annotation created="22/11/2006" annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=8816450" creator="Junko Matsuura">
<PubmedArticleSet>
<PubmedArticle>
<MedlineCitation>
<PMID>8816450</PMID>
<Article>
<ArticleTitle>
<sentence id="S1">Analysis of the <term sem="Protein_domain_or_region" id="T1" lex="ligand-binding_domain"><term sem="Protein_family_or_group" id="A1">ligand</term>-binding domain</term> of <term sem="Protein_molecule" id="T2" lex="human_retinoic_acid_receptor_alpha">human retinoic acid receptor alpha</term> by <term sem="Other" id="T3" lex="site-directed_mutagenesis">site-directed mutagenesis</term>.</sentence>
<event uncertainty="doubtful" id="E1">
<type class="Binding" />
<theme idref="A1" />
<theme idref="T2" />
<clue>Analysis of the ligand-<clueType>binding</clueType> domain of human retinoic acid receptor alpha <clueExperiment>by site-directed mutagenesis.</clueExperiment></clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">Three subtypes of <term sem="Protein_family_or_group" id="T4" lex="retinoic_acid_receptor"><term sem="Organic_compound_other" id="T5" lex="retinoic_acid">retinoic acid</term> receptors</term> (<term sem="Protein_family_or_group" id="T6" lex="RAR">RAR</term>), termed <term sem="Protein_molecule" id="T7" lex="RAR_alpha">RAR alpha</term>, <term sem="Protein_molecule" id="T8" lex="RAR_beta">RAR beta</term>, and <term sem="Protein_molecule" id="T9" lex="RAR_gamma">RAR gamma</term>, have been described.</sentence>
<sentence id="S3">They are composed of different <term sem="Protein_domain_or_region" id="T10" lex="structural_domain">structural domains</term>, including distinct domains for <term sem="DNA_molecule" id="A2">DNA</term> and <term sem="Protein_molecule" id="A3">ligand</term> binding.</sentence>
<event id="E2">
<type class="Binding" />
<theme idref="T10" />
<theme idref="A2" />
<clue>They are composed of different structural domains, including distinct domains for DNA and ligand <clueType>binding</clueType>.</clue>
</event>
<event id="E3">
<type class="Binding" />
<theme idref="T10" />
<theme idref="A3" />
<clue>They are composed of different structural domains, including distinct domains for DNA and ligand <clueType>binding</clueType>.</clue>
</event>
<sentence id="S4"><term sem="Protein_family_or_group" id="T11" lex="RAR">RARs</term> specifically bind <term sem="Organic_compound_other" id="T12" lex="all-trans-retinoic_acid">all-trans-retinoic acid</term> (<term sem="Organic_compound_other" id="T13" lex="RA">RA</term>), <term sem="Organic_compound_other" id="T14" lex="9-cis-RA">9-cis-RA</term>, and <term sem="Organic_compound_other" id="T15" lex="retinoid_analog">retinoid analogs</term>.</sentence>
<event id="E4">
<type class="Binding" />
<theme idref="T11" />
<theme idref="T13" />
<clue>RARs specifically <clueType>bind</clueType> all-trans-retinoic acid (RA), 9-cis-RA, and retinoid analogs.</clue>
</event>
<event id="E5">
<type class="Binding" />
<theme idref="T11" />
<theme idref="T14" />
<clue>RARs specifically <clueType>bind</clueType> all-trans-retinoic acid (RA), 9-cis-RA, and retinoid analogs.</clue>
</event>
<event id="E6">
<type class="Binding" />
<theme idref="T11" />
<theme idref="T15" />
<clue>RARs specifically <clueType>bind</clueType> all-trans-retinoic acid (RA), 9-cis-RA, and retinoid analogs.</clue>
</event>
<sentence id="S5">In this study, we examined the functional role of <term sem="Amino_acid_monomer" id="T16" lex="cysteine">cysteine</term> and <term sem="Amino_acid_monomer" id="A6">arginine</term> <term sem="Amino_acid_monomer" id="A7">residues in the <term sem="Protein_domain_or_region" id="T17" lex="ligand-binding_domain">ligand-binding domain</term></term> of <term sem="Protein_molecule" id="T18" lex="hRAR_alpha">hRAR alpha</term> (<term sem="Protein_molecule" id="T19" lex="hRAR_alpha-LBD">hRAR alpha-LBD</term>, <term sem="Protein_domain_or_region" id="T20" lex="amino_acids_154_to_462">amino acids 154 to 462</term>).</sentence>
<event uncertainty="doubtful" id="E9">
<type class="Regulation" />
<theme idref="T19" />
<cause idref1="A7" idref="T16" />
<clue>In this study, we examined the functional <clueType>role</clueType> <linkCause>of</linkCause> cysteine and arginine residues in the ligand-binding domain of hRAR alpha (hRAR alpha-LBD, amino acids 154 to 462).</clue>
<comment>TPS: A7</comment>
</event>
<event uncertainty="doubtful" id="E10">
<type class="Regulation" />
<theme idref="T19" />
<cause idref1="A7" idref="A6" />
<clue>In this study, we examined the functional <clueType>role</clueType> <linkCause>of</linkCause> cysteine and arginine residues in the ligand-binding domain of hRAR alpha (hRAR alpha-LBD, amino acids 154 to 462).</clue>
</event>
<sentence id="S6">All conserved <term sem="Amino_acid_monomer" id="T21" lex="cysteine">cysteine</term> and <term sem="Amino_acid_monomer" id="T22" lex="arginine_residue">arginine residues</term> in this domain were mutated by <term sem="DNA_domain_or_region" id="T55">site</term>-directed <term sem="Other" id="T23">mutagenesis</term>, and the <term sem="Protein_family_or_group" id="T24" lex="mutant_protein">mutant proteins</term> were characterized by <term sem="Other" id="T25" lex="blocking_reaction">blocking reactions</term>, <term sem="Other" id="T26" lex="ligand-binding_experiment"><term sem="Protein_family_or_group" id="T56">ligand</term>-binding experiments</term>, <term sem="Other" id="T27" lex="transactivation_assay">transactivation assays</term>, and <term sem="Other" id="T28" lex="protease_mapping"><term sem="Protein_family_or_group" id="T29" lex="protease">protease</term> mapping</term>.</sentence>
<sentence id="S7"><term sem="Other" id="T57">Changes</term> of any <term sem="Amino_acid_monomer" id="T30">cysteine residue</term> of the <term sem="Protein_domain_or_region" id="T31" lex="hRAR_alpha-LBD">hRAR alpha-LBD</term> had no significant influence on the <term sem="Other" id="T58">binding</term> of <term sem="Organic_compound_other" id="T32" lex="all-trans_RA">all-trans RA</term> or <term sem="Organic_compound_other" id="T33" lex="9-cis_RA">9-cis RA</term>.</sentence>
<event id="E13">
<type class="Mutagenesis" />
<theme idref="T30" />
<clue><clueType>Changes</clueType> <linkTheme>of</linkTheme> any cysteine residue <clueLoc>of the hRAR alpha-LBD</clueLoc> had no significant influence on the binding of all-trans RA or 9-cis RA.</clue>
<comment>Artificial</comment>
</event>
<event id="E14">
<type class="Binding" />
<theme idref="T31" />
<theme idref="T32" />
<clue>Changes of any cysteine residue of the hRAR alpha-LBD had no significant influence on the <clueType>binding</clueType> <linkTheme>of</linkTheme> all-trans RA or 9-cis RA.</clue>
<comment>NER: T31 MOD</comment>
</event>
<event id="E15">
<type class="Binding" />
<theme idref="T31" />
<theme idref="T33" />
<clue>Changes of any cysteine residue of the hRAR alpha-LBD had no significant influence on the <clueType>binding</clueType> <linkTheme>of</linkTheme> all-trans RA or 9-cis RA.</clue>
</event>
<event assertion="non-exist" id="E16">
<type class="Regulation" />
<theme idref="E14" />
<cause idref="E13" />
<clue>Changes of any cysteine residue of the hRAR alpha-LBD had no significant <clueType>influence</clueType> <linkTheme>on</linkTheme> the binding of all-trans RA or 9-cis RA.</clue>
</event>
<event assertion="non-exist" id="E17">
<type class="Regulation" />
<theme idref="E15" />
<cause idref="E13" />
<clue>Changes of any cysteine residue of the hRAR alpha-LBD had no significant <clueType>influence</clueType> <linkTheme>on</linkTheme> the binding of all-trans RA or 9-cis RA.</clue>
</event>
<sentence id="S8">Interestingly, <term sem="Amino_acid_monomer" id="T34" lex="residue_C-235">residue C-235</term> is specifically important in <term sem="Other" id="T35"><term sem="Other" id="A8">antagonist</term> binding</term>.</sentence>
<event id="E18">
<type class="Binding" />
<theme idref="A8" />
<theme idref="T31" />
<clue>Interestingly, residue C-235 is specifically important in antagonist <clueType>binding</clueType>.</clue>
<comment>NO COREFTHEME, OK</comment>
</event>
<event id="E19">
<type class="Positive_regulation" />
<theme idref="E18" />
<cause idref="T34" />
<clue>Interestingly, residue C-235 is specifically <clueType>important</clueType> <linkTheme>in</linkTheme> antagonist binding.</clue>
</event>
<sentence id="S9">With respect to <term sem="Amino_acid_monomer" id="T36" lex="arginine_residue">arginine residues</term>, only the two <term sem="Other" id="T37" lex="single_mutation">single mutations</term> of <term sem="Amino_acid_monomer" id="T38" lex="R-276">R-276</term> and <term sem="Amino_acid_monomer" id="T39" lex="R-394">R-394</term> to <term sem="Amino_acid_monomer" id="T40" lex="alanine">alanine</term> showed a dramatic decrease of <cons sem="(AND Other Other)" id="C1" lex="(AND agonist_binding antagonist_binding)"><frag id="F1">agonist</frag> and <frag id="F2">antagonist</frag> <frag id="F3">binding</frag></cons> whereas the <term sem="Other" id="T41" lex="R272A_mutation"><term sem="Amino_acid_monomer" id="T42" lex="R272A">R272A</term> mutation</term> showed only a slight effect.</sentence>
<event id="E20">
<type class="Binding" />
<theme idref="T31" />
<theme idref="F1" />
<clue>With respect to arginine residues, only the two single mutations of R-276 and R-394 to alanine showed a dramatic decrease of agonist and antagonist <clueType>binding</clueType> whereas the R272A mutation showed only a slight effect.</clue>
<comment>NO COREFTHEME</comment>
</event>
<event id="E21">
<type class="Binding" />
<theme idref="T31" />
<theme idref="F2" />
<clue>With respect to arginine residues, only the two single mutations of R-276 and R-394 to alanine showed a dramatic decrease of agonist and antagonist <clueType>binding</clueType> whereas the R272A mutation showed only a slight effect.</clue>
<comment>NO COREFTHEME</comment>
</event>
<event id="E22">
<type class="Mutagenesis" />
<theme idref="T38" />
<clue>With respect to arginine residues, only the two <clueType>single mutations</clueType> <linkTheme>of</linkTheme> R-276 and R-394 to alanine showed a dramatic decrease of agonist and antagonist binding whereas the R272A mutation showed only a slight effect.</clue>
<comment>Artificial</comment>
</event>
<event id="E23">
<type class="Mutagenesis" />
<theme idref="T39" />
<clue>With respect to arginine residues, only the two <clueType>single mutations</clueType> <linkTheme>of</linkTheme> R-276 and R-394 to alanine showed a dramatic decrease of agonist and antagonist binding whereas the R272A mutation showed only a slight effect.</clue>
<comment>Artificial</comment>
</event>
<event id="E24">
<type class="Negative_regulation" />
<theme idref="E20" />
<cause idref="E22" />
<clue>With respect to arginine residues, only the two single mutations of R-276 and R-394 to alanine showed a dramatic <clueType>decrease</clueType> <linkTheme>of</linkTheme> agonist and antagonist binding whereas the R272A mutation showed only a slight effect.</clue>
</event>
<event id="E25">
<type class="Negative_regulation" />
<theme idref="E21" />
<cause idref="E22" />
<clue>With respect to arginine residues, only the two single mutations of R-276 and R-394 to alanine showed a dramatic <clueType>decrease</clueType> <linkTheme>of</linkTheme> agonist and antagonist binding whereas the R272A mutation showed only a slight effect.</clue>
</event>
<event id="E26">
<type class="Negative_regulation" />
<theme idref="E20" />
<cause idref="E23" />
<clue>With respect to arginine residues, only the two single mutations of R-276 and R-394 to alanine showed a dramatic <clueType>decrease</clueType> <linkTheme>of</linkTheme> agonist and antagonist binding whereas the R272A mutation showed only a slight effect.</clue>
</event>
<event id="E27">
<type class="Negative_regulation" />
<theme idref="E21" />
<cause idref="E23" />
<clue>With respect to arginine residues, only the two single mutations of R-276 and R-394 to alanine showed a dramatic <clueType>decrease</clueType> <linkTheme>of</linkTheme> agonist and antagonist binding whereas the R272A mutation showed only a slight effect.</clue>
</event>
<event id="E28">
<type class="Mutagenesis" />
<theme idref="T42" />
<clue>With respect to arginine residues, only the two single mutations of R-276 and R-394 to alanine showed a dramatic decrease of agonist and antagonist binding whereas the R272A <clueType>mutation</clueType> showed only a slight effect.</clue>
<comment>Artificial</comment>
</event>
<event assertion="non-exist" id="E29">
<type class="Negative_regulation" />
<theme idref="E20" />
<cause idref="E28" />
<clue>With respect to arginine residues, only the two single mutations of R-276 and R-394 to alanine showed a dramatic decrease of agonist and antagonist binding whereas the R272A mutation showed <clueType>only a slight effect</clueType>.</clue>
</event>
<event assertion="non-exist" id="E30">
<type class="Negative_regulation" />
<theme idref="E21" />
<cause idref="E28" />
<clue>With respect to arginine residues, only the two single mutations of R-276 and R-394 to alanine showed a dramatic decrease of agonist and antagonist binding whereas the R272A mutation showed <clueType>only a slight effect</clueType>.</clue>
</event>
<sentence id="S10">For all other <term sem="Other" id="T43" lex="arginine_mutation"><term sem="Amino_acid_monomer" id="T44" lex="arginine">arginine</term> mutations</term>, no differences in affinity were detectable.</sentence>
<event id="E31">
<type class="Mutagenesis" />
<theme idref="T44" />
<clue>For all other arginine <clueType>mutations</clueType>, no differences in affinity were detectable.</clue>
<comment>Artificial</comment>
</event>
<event assertion="non-exist" id="E32">
<type class="Regulation" />
<theme idref="E20" />
<cause idref="E31" />
<clue>For all other arginine mutations, no differences <linkTheme>in</linkTheme> <corefTheme>affinity</corefTheme> were detectable.</clue>
<comment>NO CLUETYPE</comment>
</event>
<event assertion="non-exist" id="E33">
<type class="Regulation" />
<theme idref="E21" />
<cause idref="E31" />
<clue>For all other arginine mutations, no differences <linkTheme>in</linkTheme> <corefTheme>affinity</corefTheme> were detectable.</clue>
<comment>NO CLUETYPE</comment>
</event>
<sentence id="S11">The two <term sem="Other" id="T45" lex="mutation">mutations</term> <term sem="Amino_acid_monomer" id="T46" lex="R217A">R217A</term> and <term sem="Amino_acid_monomer" id="T47" lex="R294A">R294A</term> caused an increased binding efficiency for <term sem="Other" id="A11">antagonists</term> but no change in <term sem="Other" id="T59"><term sem="Other" id="A12">agonist</term> binding</term>.</sentence>
<event id="E34">
<type class="Mutagenesis" />
<theme idref="T46" />
<clue>The two <clueType>mutations</clueType> R217A and R294A caused an increased binding efficiency for antagonists but no change in agonist binding.</clue>
<comment>Artificial</comment>
</event>
<event id="E35">
<type class="Mutagenesis" />
<theme idref="T47" />
<clue>The two <clueType>mutations</clueType> R217A and R294A caused an increased binding efficiency for antagonists but no change in agonist binding.</clue>
<comment>Artificial</comment>
</event>
<event id="E36">
<type class="Binding" />
<theme idref="A11" />
<theme idref="T31" />
<clue>The two mutations R217A and R294A caused an increased <clueType>binding</clueType> efficiency <linkTheme>for</linkTheme> antagonists but no change in agonist binding.</clue>
<comment>OK</comment>
</event>
<event id="E37">
<type class="Binding" />
<theme idref="A12" />
<theme idref="T31" />
<clue>The two mutations R217A and R294A caused an increased binding efficiency for antagonists but no change in agonist <clueType>binding</clueType>.</clue>
<comment>OK</comment>
</event>
<event id="E38">
<type class="Positive_regulation" />
<theme idref="E36" />
<cause idref="E34" />
<clue>The two mutations R217A and R294A caused an <clueType>increased</clueType> binding efficiency for antagonists but no change in agonist binding.</clue>
</event>
<event id="E39">
<type class="Positive_regulation" />
<theme idref="E36" />
<cause idref="E35" />
<clue>The two mutations R217A and R294A caused an <clueType>increased</clueType> binding efficiency for antagonists but no change in agonist binding.</clue>
</event>
<event assertion="non-exist" id="E40">
<type class="Regulation" />
<theme idref="E37" />
<cause idref="E34" />
<clue>The two mutations R217A and R294A caused an increased binding efficiency for antagonists but no <clueType>change</clueType> <linkTheme>in</linkTheme> agonist binding.</clue>
</event>
<event assertion="non-exist" id="E41">
<type class="Regulation" />
<theme idref="E37" />
<cause idref="E35" />
<clue>The two mutations R217A and R294A caused an increased binding efficiency for antagonists but no <clueType>change</clueType> <linkTheme>in</linkTheme> agonist binding.</clue>
</event>
<sentence id="S12">From these results, we can conclude that <term sem="Other" id="T48" lex="electrostatic_interaction">electrostatic interactions</term> of <term sem="Organic_compound_other" id="T49" lex="retinoid">retinoids</term> with the <term sem="Protein_domain_or_region" id="T50" lex="RAR_alpha-LBD"><term sem="Protein_molecule" id="T51" lex="RAR_alpha">RAR alpha</term>-LBD</term> play a significant role in <term sem="Other" id="T52" lex="ligand_binding"><term sem="Protein_family_or_group" id="A13">ligand</term> binding</term>.</sentence>
<event id="E42">
<type class="Binding" />
<theme idref="T49" />
<theme idref="T50" />
<clue>From these results, we can conclude that electrostatic <clueType>interactions</clueType> <linkTheme>of</linkTheme> retinoids <linkTheme>with</linkTheme> the RAR alpha-LBD play a significant role in ligand binding.</clue>
<comment>NER: T50 MOD</comment>
</event>
<event id="E43">
<type class="Binding" />
<theme idref="A13" />
<theme idref="T51" />
<clue>From these results, we can conclude that electrostatic interactions of retinoids with the RAR alpha-LBD play a significant role in ligand <clueType>binding</clueType>.</clue>
</event>
<event id="E44">
<type class="Positive_regulation" />
<theme idref="E43" />
<cause idref="E42" />
<clue>From these results, we can conclude that electrostatic interactions of retinoids with the RAR alpha-LBD <clueType>play</clueType> a <clueType>significant role</clueType> <linkTheme>in</linkTheme> ligand binding.</clue>
</event>
<sentence id="S13">In addition, <term sem="Other" id="A14">antagonists</term> show distinctly different requirements for efficient binding, which may contribute to their interference in the <term sem="Protein_family_or_group" id="A15">ligand</term>-inducible <term sem="Other" id="T60">transactivation function</term> of <term sem="Protein_molecule" id="T54" lex="RAR_alpha">RAR alpha</term>.</sentence>
<event id="E45">
<type class="Binding" />
<theme idref="A14" />
<theme idref="T50" />
<clue>In addition, antagonists show distinctly different requirements for efficient <clueType>binding</clueType>, which may contribute to their interference in the ligand-inducible transactivation function of RAR alpha.</clue>
<comment>NO COREFTHEME, OK</comment>
</event>
<event id="E46">
<type class="Positive_regulation" />
<theme idref="T54" />
<cause idref="A15" />
<clue>In addition, antagonists show distinctly different requirements for efficient binding, which may contribute to their interference in the ligand-<linkCause>inducible</linkCause> <clueType>transactivation</clueType> function <linkTheme>of</linkTheme> RAR alpha.</clue>
</event>
<event id="E47">
<type class="Negative_regulation" />
<theme idref="E46" />
<cause idref="A14" />
<clue>In addition, antagonists show distinctly different requirements for efficient binding, which may contribute to <linkCause>their</linkCause> <clueType>interference</clueType> in the ligand-inducible transactivation function of RAR alpha.</clue>
</event>
</AbstractText>
</Abstract>
</Article>
</MedlineCitation>
</PubmedArticle>
</PubmedArticleSet>
</Annotation>
